FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions relate to field of medicine, in particular, to ophthalmology. Method of stabilisation of eye composition, which includes oxidatively unstable pharmaceutical ingredient is ensured by addition of efficient quantity of stabilising substance, where stabilising substance is selected from group, which consists of silicon dioxide, N,N,N',N',N",N"-hexa(2-pyridyl)-1,3,5- tris(aminomethyl)benzene, diethylenetriaminepentaacetic acid and salts of diethylenetriaminepentaacetic acid. Eye composition has pH from approximately 6.6 to approximately 7.2.
EFFECT: group of inventions ensures efficiency and stability of eye composition at higher temperatures.
32 cl, 2 tbl, 3 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS AND DEVICES FOR DIFFUSION RATE TESTING OF INTRAOCULAR DRUG DELIVERY SYSTEMS | 2007 |
|
RU2431468C2 |
| COMPOSITIONS AND METHODS FOR EYE TREATMENT | 2019 |
|
RU2793736C2 |
| KETOTHIPHEN OPTICALLY ACTIVE ISOMERS AND THEIR THERAPEUTICALLY ACTIVE METABOLITES | 2000 |
|
RU2266115C2 |
| APPARATUS AND METHOD OF SIMULATING EYE AMBIENT ENVIRONMENT | 2007 |
|
RU2443999C2 |
| BENZOCYCLOHEPTATHIOPHENE COMPOUNDS, METHODS OF PROPHYLAXIS OR TREATMENT, PHARMACEUTICAL COMPOSITION | 1998 |
|
RU2193557C2 |
| COMPOSITIONS AND METHODS OF TREATING EYE DISORDERS | 2019 |
|
RU2802365C2 |
| PIPERACILLIN AND TAZOBACTAM-CONTAINING COMPOSITIONS USED FOR INJECTION | 2004 |
|
RU2322980C2 |
| COMPOSITIONS AND METHODS FOR TREATING EYE DISORDERS | 2019 |
|
RU2792627C2 |
| ANTIMICROBIAL LENS | 2007 |
|
RU2434646C2 |
| BISPHOSPHONATE-CONTAINING PHARMACEUTICAL PARENTERAL COMPOSITION | 2001 |
|
RU2238736C2 |
